The company strategy is to exercise the five pillars of success follow by: Elite business development, business intelligence, IP & litigation expert, data science and strategic regulatory affairs. Those merits allow us to lead the “First-to-Market” strategy. We aim to achieve this through; strategic alliances, product development, and licensing of specialty pharmaceutical products globally. Our company goal is to achieve 80% of our launches as “First-to-Market” products. We are striving to improve and secure our products portfolio and market of operations based on ‘Blue Ocean Strategy’, where low competition and high growth is expected. Our laser focus on early launch opportunities is our leading catalyst for success within our stable business environment. Our innovative technological advances allow us to be “one step ahead” of our competitors allowing for our fast and efficient business.